Literature DB >> 1618774

Hemoglobin Thionville. An alpha-chain variant with a substitution of a glutamate for valine at NA-1 and having an acetylated methionine NH2 terminus.

C Vasseur1, Y Blouquit, J Kister, D Promé, J S Kavanaugh, P H Rogers, C Guillemin, A Arnone, F Galacteros, C Poyart.   

Abstract

In hemoglobin (Hb) Thionville, the substitution of a glutamic acid for the alpha-chain NH2-terminal valine inhibits the cleavage of the initiator methionine which is then acetylated. The elongation of the alpha-chain NH2 terminus modifies the three-dimensional structure of hemoglobin at a region that is known to have an important role in the allosteric regulation of oxygen binding. Relative to Hb A, Hb Thionville has a lower affinity for oxygen, and the heterotropic allosteric effects of protons, chloride, and bezafibrate are reduced. In contrast, the response to 2,3-diphosphoglycerate is normal. Analysis of oxygen equilibrium data within the framework of the two-state allosteric model indicates that the structure of deoxy Hb Thionville is stabilized relative to that of deoxy Hb A. The x-ray crystal structure of deoxy Hb Thionville shows that the glutamate side chain extends away from the alpha 1-alpha 2 interface, whereas the methionine side chain (which has two conformations) extends into the alpha 1-alpha 2 interface, physically displacing chloride and bezafibrate. The increased stability of deoxy Hb Thionville is due to new intrasubunit and intersubunit contacts made by the methionine. These interactions replace the indirect contacts, made through bound chloride ions, that Val-1 alpha normally contributes to the alpha 1-alpha 2 interface.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618774

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Characterization of the elusive disulfide bridge forming human Hb variant: Hb Ta-Li beta83 (EF7)Gly --> Cys by electrospray mass spectrometry.

Authors:  Dilip K Rai; Britta Landin; William J Griffiths; Gunvor Alvelius; Brian N Green
Journal:  J Am Soc Mass Spectrom       Date:  2002-02       Impact factor: 3.109

2.  MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease.

Authors:  Melanie Demers; Sarah Sturtevant; Kevin R Guertin; Dipti Gupta; Kunal Desai; Benjamin F Vieira; Wenjing Li; Alexandra Hicks; Ayman Ismail; Bronner P Gonçalves; Giuseppe Di Caprio; Ethan Schonbrun; Scott Hansen; Faik N Musayev; Martin K Safo; David K Wood; John M Higgins; David R Light
Journal:  Blood Adv       Date:  2021-03-09

3.  Structural plasticity of an aminoacyl-tRNA synthetase active site.

Authors:  James M Turner; James Graziano; Glen Spraggon; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-17       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.